CTRI/2015/05/005783已完成3 期
A Multicentric, Double Blind, Randomized, Active Control, Parallel Group Comparative Study to Evaluate the Efficacy, Safety and Tolerability of 2% Rebamipide Ophthalmic Suspension Vs. 0.1 % Sodium Hyaluronate Ophthalmic solution for treatment of patients with Dry Eye.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 8
- 主要终点
- To determine Efficacy of 2% Rebamipide Ophthalmic Suspension compared to 0.1% Sodium Hyaluronate for the treatment of patients with Dry eye.
研究概览
简要总结
A Multicentric, Double Blind, Randomized, Active Control, Parallel Group Comparative Study to Evaluate the Efficacy, Safety and Tolerability of 2% Rebamipide Ophthalmic Suspension Vs. 0.1 % Sodium Hyaluronate Ophthalmic solution for treatment of patients with Dry Eye.
Dry eye is a condition characterized by a patient’s inability to produce enough tears or the appropriate quality of tears to keep the eye healthy and comfortable. xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /
The primary end point will be assessed by the change in Fluorescein Corneal Staining (FCS) Score at every visit for 24 weeks of treatment.
The secondary end points are Foreign Body Sensation, Dryness, Photophobia, Eye Pain and blurred vision will be assessed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1.A clinical diagnosis Dry Eye at least since from 20 months.
- •2.Anesthetized Schirmer test score of 0 to 9 mm per 5minutes or less or tear breakup time is 5 seconds or less.
- •3.Best corrected visual acuity of 0.2 or better in both eyes.
- •4.Voluntary willingness to give written informed consent prior to participation in trial.
- •5.Wash out period for subjects who are on medications for same condition will be 3 days.
排除标准
- •1.Any active inflammation of eyes.
- •2.Any long lasting inflammation of eyes.
- •3.Subject with block nasal duct.
- •4.Subjects with history of recurrent corneal erosions diagnosed by slit lamp examination.
- •5.Subjects with history of epithelial basement membrane dystrophy.
- •6.Subjects with history of floppy eyelid syndrome diagnosed by Slit lamp examination 7.Subjects with history of Conjunctivochalasis diagnosed by slit lamp examination 8.Anterior segment disease like Glaucoma or Ocular Hypertension.
- •9.Using Cyclosporine since long time 10.Use of contact lenses 11.Use of topically instilled Ocular medication during study.
- •12.History of Ocular surgery within 12 months.
- •13.Females who are pregnant, lactating, or child bearing potential.
- •14.Females who are not willing to remain abstinent or use contraception.
- •15.Subjects who are on systemic Hormonal or corticosteroid therapy.
- •18.Ocular surgery due to Dry eye Syndrome.
- •19.Use of topical &/or systemic treatment potentially interfering with tear production.
- •20.Concurrent involvement in another study or previous receipt of same drug.
- •21.Any ocular condition that, in the opinion of the investigator, could affect the subject’s safety or trial parameters.
- •22.Known contraindications or sensitivities to the study medication or its components.
- •23.Other patients who are in the opinion of the investigator/sub investigator were inappropriate for the study participation.
结局指标
主要结局
To determine Efficacy of 2% Rebamipide Ophthalmic Suspension compared to 0.1% Sodium Hyaluronate for the treatment of patients with Dry eye.
时间窗: Day1, 4th week, 8th week, 12thweek, 16th week, 20thweek, 24thweek
次要结局
- •To determine Safety and Tolerability of 2% Rebamipide Ophthalmic Suspension Compared to 0.1% Sodium Hyaluronate in patients with Dry eye(•Global assessment of study medication by Investigators and Patients)
研究者
研究点 (8)
Loading locations...
相似试验
已完成
3 期
A Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Nepafenac Ophthalmic Suspension 0.3% w/v compared to Bromfenac Ophthalmic Solution 0.09% w/v in the treatment of Pain and Inflammation post Cataract Surgery.Disorders of the eye following cataract surgery, Pain and Inflammation in the Eye associated with Cataract Surgery,CTRI/2017/04/008299Ajanta Pharma Ltd278
已完成
3 期
A clinical trial to study the effect of Fixed Dose Combination of Microsphere Tretinoin and Clindamycin gel in the treatment of patients with acne vulgaris.Acne VulgarisCTRI/2012/03/002472Glenmark Pharmaceuticals Ltd438
招募中
3 期
A clinical trial to study the effects of Carbetocin Injection in prevention of uterine atony after cesarean sectionPrevention of uterine atony after cesarean sectionCTRI/2011/091/000045Precise Chemipharma Pvt Ltd200
尚未招募
3 期
A clinical study to evaluate the efficacy, safety & tolerability of Semaglutide oral tablets in patients with Inadequately Controlled Type 2 Diabetes Mellitus.Type 2 diabetes mellitus without complications,CTRI/2025/06/088110Dr. Reddy’s Laboratories Ltd.288
尚未招募
3 期
A study of Denosumab in patients.Age-related osteoporosis without current pathological fracture,CTRI/2021/09/036190Intas Pharmaceutical Limited Biopharma Division552